U.S. Stem Cell, Inc. Opens Regenerative Wellness Clinic in West Palm Beach; Appoints Rosemary Daly Head of West Palm Beach Clinic
November 01, 2017 at 06:34 pm IST
Share
U.S. Stem Cell, Inc. announced the opening of another regenerative clinic using its proprietary products and services, bringing the number of clinics using its technology to 287. Regenerative Wellness Clinic (RWC), located in West Palm Beach, represents another addition to the company's global distribution platform for its proprietary, stem cell technology, and is a direct result of it's position as the educator in stem cell innovation and physician training, with more than 700 USRM certified stem cell physicians globally. The minimally invasive, proprietary procedure - which utilizes a patient's own stem-cell-rich adipose or fat tissue - has, management believes, significantly boosted success rate for patient outcomes in a wide variety of indications including pain management, orthopedic, autoimmune, cardiac and other systemic conditions.
The West Palm Beach clinic is spearheaded by Dr. Rosemary Daly, an interventional spine/pain management physician, board certified in Anesthesiology and Pain Medicine.
U.S. Stem Cell, Inc. is a biotechnology company. The Company is focused on the discovery, development and subject to regulatory approval and commercialization of autologous cell therapies for the treatment of chronic and acute heart damage. The Company's product candidates are MyoCell, MyoCell SDF-1 and Adipocell. MyoCell and MyoCell SDF-1 product candidates are clinical therapies designed to populate regions of scar tissue within a patient's heart with autologous muscle cells, or cells from a patient's body, for the purpose of improving cardiac function in chronic heart failure patients. MyoCell SDF-1 is similar to MyoCell except that the myoblast cells to be injected for use in MyoCell SDF-1 will be modified prior to injection by an adenovirus vector or non-viral vector. Adipocell product candidate is a cell therapy kit with multiple possible treatment applications using autologous adipose cells. It is also investigating the use of adipose cells in a variety of clinical applications.
U.S. STEM CELL, INC. 
